Gypenoside was found to induce apoptosis in HGC‐27 and SGC‐7901 gastric cancer cells in a dose‐ and time‐dependent manner by targeting the PI3K/AKT/mTOR signaling pathway, as confirmed through network pharmacology, molecular docking, and western blot analyses. Here, AKT1 is linked to gastric cancer.